Texas Archive of the Moving Image is loading...

5 to 1

Texas Central Hemophilia Association

Sound | c. 1970's

  • Normal
  • Large video
  • Large content
  • Full video
"rtmpconf":{ type:"flv", file:"mp4:2009_03826_480x360.mp4", baseUrl:wgScriptPath + "/extensions/player/", streamServer:'texas-flash.streamguys1.com:443/vod', width:"480", height:"360", config:{ showBrowserControls:false }, poster:"/library/index.php?action=ajax%26rs=importImage%26rsargs[]=5 to 1 tn.jpg%26rsargs[]=480", controls:{ _timerStyle:"sides" } }
  •  Dr. Rogers explains hematology and hemophilia.  
  •  Dr. Hill explains the fractionation of blood.  
  •  Dr. Rogers discusses advancements in the field.  
  •  President of the Hemophilia Foundation Paul Johnson discusses the struggles hemophiliacs face.  
  •  Dr. Rogers explains how parents should approach hemophilia and where to donate blood.  
Loading Google Maps...
Mark Video Segment:
See someone or something you recognize? TAMI Tagging
Click begin and end to mark the segment you wish
to tag. Then enter your comment and click on Tag!
To: tamitags@texasarchive.org
Share this video

Send E-mail


[Hide]Right click this link, select 'open in new tab', and add to bookmarks:
In partnership with:
  • About the video
  • Texas Locations
  • Keywords
Presented by the Dallas Chapter of the National Hemophilia Association, this film details many aspects of blood plasma fractionation, the process by which blood is separated into individual useful components that can be concentrated and injected directly into patients' blood. A panel of prominent chapter members discusses the processes, including the collection of blood from donors, fractionation systems and procedures, and the benefits to patients. At the time this film was produced, the concept of fractionating blood was in its infancy, but the possibilities were endless to doctors specializing in blood and clotting disorders. The National Hemophilia Association was established in 1948 with a mission to find better treatment options and possible cures for bleeding and clotting disorders and to promote education on these diseases and advocacy for patients.